SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (9529)6/11/1998 7:04:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
just a bit of positive news:

Insurance companies are now reimbursing for the in clinic titration for MUSE. This will help create a more informed patient. Since the doctor knows he will be reimbursed he will gladly take the time to give proper instructions rather than just writing a script.

Poor instruction has in the past been one reason patients have not had success.



To: DaiS who wrote (9529)6/11/1998 7:11:00 PM
From: Frostman  Read Replies (1) | Respond to of 23519
 
DiaS, I think the FDA plant aproval for Vivus will happen before the end of this month. If that time-line advances a conspiracy theory, so be it. (g)

Frostman


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News